Update Note: This article reports new information involving Dr. Heidi Overton's nomination to lead the Food and Drug Administration following MedicalDaily's earlier coverage. The latest development, reported by STAT on September 29, 2026, is that the Senate health committee has no vote scheduled before the Senate leaves for the midterm elections.
The Senate health committee is not expected to vote on Dr. Heidi Overton's nomination as FDA commissioner before the November midterm elections, STAT reported. This is the Senate's last week in session until November 9, and Overton was not included in the committee's September 30 vote on three other health nominees.
